Caplin Point Labs acquires 10 ANDAs, targets $473M US market
The portfolio, purchased from a leading multinational generic manufacturer, addresses a market valued at $473.2 million for the 12 months ending August 2025
The portfolio, purchased from a leading multinational generic manufacturer, addresses a market valued at $473.2 million for the 12 months ending August 2025
Motiva, SmoothSilk, Round and Ergonomix implants represent the latest in plastic surgery innovation
The plant is expected to enhance regional supply capabilities
The partnership also sets the stage for broader collaboration on rare disease treatments
The proceeds from the QIP will be used primarily to accelerate the nationwide expansion of the COCO stores of Davaindia nationwide
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
Nona aims to help global biopharmaceutical companies fast-track clinical trial initiation without compromising scientific rigor or quality standards
The new single-use commercial facility will be among India’s largest, featuring advanced technologies to produce high-quality biologics and specialty pharmaceuticals
The opening of our 1000th pharmacy in Karnataka marks an important step
Provides pain relief for more than 30 conditions, including chronic back pain, arthritis, and sports injuries
Subscribe To Our Newsletter & Stay Updated